[1] Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity:an analysis of 32 cases and a comprehensive review of the literature[J]. Am J Surg Pathol, 2004, 28:1-30. [2] David K, Revesz T, Kratimenos G, Krausz T, Crockard HA. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor:case report[J]. J Neurosurg, 1996, 84:288-292. [3] Gonzalez-Compta X, Mañós-Pujol M, Foglia-Fernandez M, Peral E, Condom E, Claveguera T, Dicenta-Sousa M. Oncogenic osteomalacia:case report and review of head and neckassociated tumours[J]. J Laryngol Otol, 1998, 112:389-392. [4] Reis-Filho JS, Paiva ME, Lopes JM. August 2003:47-year-old female with a 7-year history of osteomalacia and hypophosphatemia[J]. Brain Pathol, 2004, 14:111-112. [5] Yoshioka K, Nagata R, Ueda M, Yamaguchi T, Konishi Y, Hosoi M, Inoue T, Yamanaka K, Iwai Y, Sato T. Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy[J]. Intern Med, 2006, 45:1157-1160. [6] Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, Chang R, Collins MT. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors[J]. J Bone Miner Res, 2011, 26:1295-1302. [7] Uno T, Kawai K, Kunii N, Fukumoto S, Shibahara J, Motoi T, Saito N. Osteomalacia caused by skull base tumors:report of 2 cases[J]. Neurosurgery, 2011, 69:E239-244. [8] Bower RS, Daugherty WP, Giannini C, Parney IF. Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia[J]. Surg Neurol Int, 2012, 3:151. [9] Mathis DA, Stehel EJ Jr, Beshay JE, Mickey BE, Folpe AL, Raisanen J. Intracranial phosphaturic mesenchymal tumors:report of 2 cases[J]. J Neurosurg, 2013, 118:903-907. [10] Tarasova VD, Trepp-Carrasco AG, Thompson R, Recker RR, Chong WH, Collins MT, Armas LA. Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy[J]. J Clin Endocrinol Metab, 2013, 98:4267-4272. [11] Fathalla H, Cusimano M, Di Ieva A, Karamchandani J, Fung R, Kovacs K. Osteomalacia-inducing tumors of the brain:a case report, review and a hypothesis[J]. World Neurosurg, 2015, 84:189. [12] Li H, Tan S. Intracranial phosphaturic mesenchymal tumor:one case report and literature reviews[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2015, 22:1488-1490.[李红,谈顺.颅骨磷酸盐尿性间叶性肿瘤一例报告并文献复习[J].中华肿瘤防治杂志, 2015, 22:1488-1490.] [13] Ellis MB, Gridley D, Lal S, Nair GR, Feiz-Erfan I. Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl:case report[J]. J Neurosurg Pediatr, 2016, 17:573-577. [14] Li Y, Li ZY, Zhong DR. Phosphaturic mesenchymal tumor originated from central nerve system[J]. Zhen Duan Bing Li Xue Za Zhi, 2018, 25:401-405.[李媛,李致远,钟定荣.中枢神经系统原发性磷酸盐尿性间叶性肿瘤[J].诊断病理学杂志, 2018, 25:401-405.] [15] Tenenhouse HS. Phosphate transport:molecular basis, regulation and pathophysiology[J]. J Steroid Biochem Mol Biol, 2007, 103:572-577. [16] Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, Horch RE, Schmolders J, Hartmann A, Haller F, Michal M. Phosphaturic mesenchymal tumors:clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum[J]. Am J Surg Pathol, 2017, 41:1371-1380. [17] Li DM, Wu HW, Li JD, Xia WB, Jiang Y, Zhong DR. Clinical and immunohistochemical study of phosphaturic mesenchymal tumors[J]. Zhonghua Bing Li Xue Za Zhi, 2018, 47:427-431.[李冬梅,吴焕文,李敬东,夏维波,姜艳,钟定荣.磷酸盐尿性间叶肿瘤的临床及免疫组织化学特点分析[J].中华病理学杂志, 2018, 47:427-431.] [18] Folpe AL. Phosphaturic mesenchymal tumors:a review and update[J]. Semin Diagn Pathol, 2019, 36:260-268. [19] John JR, Hephzibah J, Oommen R, Shanthly N, Mathew D. Ga-68 DOTATATE positron emission tomography-computed tomography imaging in oncogenic osteomalacia:experience from a tertiary level hospital in South India[J]. Indian J Nucl Med, 2019, 34:188-193. [20] Ha S, Park S, Kim H, Go H, Lee SH, Choi JY, Hong JY, Ryu JS. Successful localization using 68 Ga-DOTATOC PET/CT of a phosphaturic mesenchymal tumor causing osteomalacia in a patient with concurrent follicular lymphoma[J]. Nucl Med Mol Imaging, 2018, 52:462-467. [21] Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors:a polymorphous group causing osteomalacia or rickets[J]. Cancer, 1987, 59:1442-1454. [22] Wu H, Bui MM, Zhou L, Li D, Zhang H, Zhong D. Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws:clinicopathological and immunohistochemical analysis of 22 cases with literature review[J]. Mod Pathol, 2019, 32:189-204. |